Posted by on May 2, 2018 1:03 pm
Tags:
Categories: Crispr Articles

Source: As CRISPR patent fight nears the end game, where are settlement talks?

T

hree years after the University of California and the Broad Institute began battling over key patents on CRISPR-Cas9 genome editing inventions, the fat lady is finally about to sing in this multimillion-dollar operatic battle.

The U.S. Court of Appeals for the Federal Circuit, which heard oral arguments in the case on Monday, is expected to rule within 90 days on whether the Broad can keep its foundational CRISPR patents, as the patent office ruled last year. (IP experts think the chances of the Supreme Court accepting the case, if the losing party tries that route, are comparable to those of the Baltimore Orioles winning the 2018 World Series.)

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It’s easy! Your first 30 days are free and if you don’t enjoy your subscription you can cancel any time.

Already a subscriber? Log in here.

Published at Wed, 02 May 2018 08:45:26 +0000

Leave a Reply